Predictive factors, microbiology and outcome of patients with parapneumonic effusion

European Respiratory Journal

Volumn 38, Issue 5, 2011, Pages 1173-1179

  Falguera, M ^a   Carratala J ^b   Bielsa, S ^a   Garcia Vidal C ^b   Ruiz Gonzalez A ^a   Chica, I ^a   Gudiol, F ^b   Porcel, J M ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Community acquired pneumonia; Empyema; Pleural effusion

Indexed keywords

AGE; AGED; ALCOHOLISM; ANAEROBIC BACTERIUM; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; GRAM POSITIVE COCCI; HUMAN; LENGTH OF STAY; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; PAIN; PARAPNEUMONIC EFFUSION; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURITIC PAIN; PRIORITY JOURNAL; PROGNOSIS; TACHYCARDIA;

ADULT; AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; EMPYEMA, PLEURAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION; PNEUMONIA, BACTERIAL; PROGNOSIS; RISK FACTORS;

EID: 80355138038     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00000211     Document Type: Article

References (28)

1. Porcel JM. Pearls and myths in pleural fluid analysis. Respirology 2011; 16: 44-52.
2. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions. An evidence-based guideline. Chest 2000; 18: 1158-1171.
3. Sahn SA. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas. Thorax 1998; 53: 65-72.
4. Lindstrom ST, Kolbe J. Community-acquired parapneumonic thoracic empyema: predictors of outcome. Respirology 1999; 4: 173-179. (Pubitemid 29268717)
5. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001; 344: 665-671. (Pubitemid 32183583)
6. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250. (Pubitemid 27044625)
7. Lim WS, van der Eerden MM, Laing R, et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-382. (Pubitemid 36560938)
8. Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med 1980; 69: 507-512. (Pubitemid 10018705)
9. Hosmer DW, Lemeshow S. Model-building strategies and methods for logistic regression. In: Hosmer DW, Lemeshow S, eds. Applied Logistic Regression. 2nd Edn. New York, John Wiley and Sons, 2000; pp. 91-142.
10. Boersma WG, Daniels JMA, Löwenberg A, et al. Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia. Respir Med 2006; 100: 926-932.
11. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: 27-72.
12. Lim WS, Baudouin SV, George RC, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: 1-55.
13. Phua J, See KC, Chan YH, et al. Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Thorax 2009; 64: 598-603.
14. Viegi G, Pistelli R, Cazzola M, et al. Epidemiological survey on incidence and treatment of community-acquired pneumonia in Italy. Respir Med 2006; 100: 46-55. (Pubitemid 43033379)
15. Luna CM, Famiglietti A, Absi R, et al. Community-acquired pneumonia. Etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest 2000; 118: 1344-1354.
16. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1136-1180.
17. Roth M, Hal Cragun LTC, Grathwohl CPT. Complications associated with thoracocentesis. Arch Intern Med 1991; 151: 2095-2096.
18. Collins TR, Sahn SA. Thoracocentesis. Clinical value, complications, technical problems, and patient experience. Chest 1987; 91: 817-822.
19. Gordon CE, Feller-Kopman D, Balk EM, et al. Pneumothorax following thoracentesis. A systematic review and meta-analysis. Arch Intern Med 2010; 170: 332-339.
20. Ahmed RA, Marrie TJ, Huang JQ. Thoracic empyema in patients with community-acquired pneumonia. AmJ Med 2006; 119: 877-883. (Pubitemid 44415617)
21. Chalmers JD, Singanayagam A, Murray MP, et al. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax 2009; 64: 592-597.
22. Barlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis 1993; 16: 248-255.
23. Alfagame I, Muñoz F, Pena N, et al. Empyema of the thorax in adults, etiology, microbiologic findings and management. Chest 1993; 103: 839-843. (Pubitemid 23086185)
24. Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997; 157: 1453-1459. (Pubitemid 27300393)
25. Kauppinen MT, Saikku P, Kujala P, et al. Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax 1996; 51: 185-189. (Pubitemid 26060656)
26. Falguera M, Trujillano J, Caro S, et al. A prediction rule for estimating the risk of bacteremia in patients with communityacquired pneumonia. Clin Infect Dis 2009; 49: 409-416.
27. Maskell NA, Batt S, Hedley EL, et al. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006; 174: 817-823. (Pubitemid 44511664)
28. García-Vidal C, Carratalà J, Díaz V, et al. Factors associated with prolonged hospital stay in community-acquired pneumonia. Enferm Infecc Microbiol Clin 2009; 27: 160-164.